Medical Developments International Ltd (MVP) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.013x

Based on the latest financial reports, Medical Developments International Ltd (MVP) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$709.00K ≈ $501.66K USD) by net assets (AU$55.10 Million ≈ $38.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MVP net asset quality index to measure how much of total assets are equity-financed.

Medical Developments International Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Medical Developments International Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medical Developments International Ltd (MVP) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Medical Developments International Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medical Developments International Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
AS Ekspress Grupp
F:DYC
-0.002x
Lien Chang Electronic Enterprise Co Ltd
TW:2431
-0.008x
Can Don Hydro Power JSC
VN:SJD
-0.008x
Black Canyon Ltd
AU:BCA
-0.044x
Petrolia SE
OL:PSE
0.238x
HYUNDAI BIOLAND Co.Ltd
KQ:052260
0.102x
Heimstaden AB Pfd.
ST:HEIM-PREF
0.002x
Bluerock Homes Trust Inc.
NYSE MKT:BHM
0.021x

Annual Cash Flow Conversion Efficiency for Medical Developments International Ltd (2004–2025)

The table below shows the annual cash flow conversion efficiency of Medical Developments International Ltd from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see MVP company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$55.10 Million
≈ $38.99 Million
AU$-43.00K
≈ $-30.43K
-0.001x +99.67%
2024-06-30 AU$45.73 Million
≈ $32.36 Million
AU$-10.78 Million
≈ $-7.63 Million
-0.236x -16.20%
2023-06-30 AU$81.31 Million
≈ $57.54 Million
AU$-16.50 Million
≈ $-11.67 Million
-0.203x -8.40%
2022-06-30 AU$57.30 Million
≈ $40.54 Million
AU$-10.72 Million
≈ $-7.59 Million
-0.187x -45.11%
2021-06-30 AU$68.30 Million
≈ $48.33 Million
AU$-8.81 Million
≈ $-6.23 Million
-0.129x -3349.26%
2020-06-30 AU$43.34 Million
≈ $30.66 Million
AU$172.00K
≈ $121.70K
0.004x -99.17%
2019-06-30 AU$44.59 Million
≈ $31.55 Million
AU$21.27 Million
≈ $15.05 Million
0.477x +460.77%
2018-06-30 AU$21.04 Million
≈ $14.89 Million
AU$1.79 Million
≈ $1.27 Million
0.085x -54.19%
2017-06-30 AU$21.60 Million
≈ $15.28 Million
AU$4.01 Million
≈ $2.84 Million
0.186x -70.72%
2016-06-30 AU$19.02 Million
≈ $13.46 Million
AU$12.07 Million
≈ $8.54 Million
0.634x +228.69%
2015-06-30 AU$17.41 Million
≈ $12.32 Million
AU$3.36 Million
≈ $2.38 Million
0.193x +135.79%
2014-06-30 AU$15.82 Million
≈ $11.20 Million
AU$1.29 Million
≈ $916.30K
0.082x +31.75%
2013-06-30 AU$15.73 Million
≈ $11.13 Million
AU$977.00K
≈ $691.29K
0.062x -68.60%
2012-06-30 AU$16.17 Million
≈ $11.44 Million
AU$3.20 Million
≈ $2.26 Million
0.198x -5.67%
2011-06-30 AU$14.46 Million
≈ $10.23 Million
AU$3.03 Million
≈ $2.14 Million
0.210x +47.18%
2010-06-30 AU$12.71 Million
≈ $8.99 Million
AU$1.81 Million
≈ $1.28 Million
0.142x +31.08%
2009-06-30 AU$11.81 Million
≈ $8.36 Million
AU$1.28 Million
≈ $908.51K
0.109x +4.45%
2008-06-30 AU$11.80 Million
≈ $8.35 Million
AU$1.23 Million
≈ $868.89K
0.104x -9.48%
2007-06-30 AU$11.02 Million
≈ $7.80 Million
AU$1.27 Million
≈ $896.48K
0.115x -1.48%
2006-06-30 AU$9.87 Million
≈ $6.99 Million
AU$1.15 Million
≈ $815.11K
0.117x +72.27%
2005-06-30 AU$8.40 Million
≈ $5.94 Million
AU$569.00K
≈ $402.60K
0.068x +41.46%
2004-06-30 AU$8.37 Million
≈ $5.93 Million
AU$401.00K
≈ $283.73K
0.048x --

About Medical Developments International Ltd

AU:MVP Australia Drug Manufacturers - Specialty & Generic
Market Cap
$36.67 Million
AU$51.82 Million AUD
Market Cap Rank
#23043 Global
#863 in Australia
Share Price
AU$0.46
Change (1 day)
+6.98%
52-Week Range
AU$0.37 - AU$0.76
All Time High
AU$11.06
About

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more